These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 21132403
1. Quantitative proteomic analysis identifying three annexins as lymph node metastasis-related proteins in lung adenocarcinoma. Liu YF, Chen YH, Li MY, Zhang PF, Peng F, Li GQ, Xiao ZQ, Chen ZC. Med Oncol; 2012 Mar; 29(1):174-84. PubMed ID: 21132403 [Abstract] [Full Text] [Related]
2. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. Liu YF, Xiao ZQ, Li MX, Li MY, Zhang PF, Li C, Li F, Chen YH, Yi H, Yao HX, Chen ZC. J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225 [Abstract] [Full Text] [Related]
3. Prognostic significance of annexin II expression in non-small cell lung cancer. Luo CH, Liu QQ, Zhang PF, Li MY, Chen ZC, Liu YF. Clin Transl Oncol; 2013 Nov; 15(11):938-46. PubMed ID: 23529818 [Abstract] [Full Text] [Related]
4. Identification of annexin A1 as a proinvasive and prognostic factor for lung adenocarcinoma. Liu YF, Zhang PF, Li MY, Li QQ, Chen ZC. Clin Exp Metastasis; 2011 Jun; 28(5):413-25. PubMed ID: 21365324 [Abstract] [Full Text] [Related]
5. Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. Yao H, Zhang Z, Xiao Z, Chen Y, Li C, Zhang P, Li M, Liu Y, Guan Y, Yu Y, Chen Z. Lung Cancer; 2009 Jul; 65(1):41-8. PubMed ID: 19058872 [Abstract] [Full Text] [Related]
6. Identification of flotillin-1 as a novel biomarker for lymph node metastasis and prognosis of lung adenocarcinoma by quantitative plasma membrane proteome analysis. Zhang PF, Zeng GQ, Hu R, Li C, Yi H, Li MY, Li XH, Qu JQ, Wan XX, He QY, Li JH, Chen Y, Ye X, Li JY, Wang YY, Feng XP, Xiao ZQ. J Proteomics; 2012 Dec 21; 77():202-14. PubMed ID: 22982323 [Abstract] [Full Text] [Related]
8. Identification and Characterization of Potential Biomarkers by Quantitative Tissue Proteomics of Primary Lung Adenocarcinoma. Hsu CH, Hsu CW, Hsueh C, Wang CL, Wu YC, Wu CC, Liu CC, Yu JS, Chang YS, Yu CJ. Mol Cell Proteomics; 2016 Jul 21; 15(7):2396-410. PubMed ID: 27161446 [Abstract] [Full Text] [Related]
9. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma. Zheng YZ, Ma R, Zhou JK, Guo CL, Wang YS, Li ZG, Liu LX, Peng Y. Sci Rep; 2016 Nov 10; 6():36447. PubMed ID: 27830754 [Abstract] [Full Text] [Related]
10. Galectin-4, a novel predictor for lymph node metastasis in lung adenocarcinoma. Hayashi T, Saito T, Fujimura T, Hara K, Takamochi K, Mitani K, Mineki R, Kazuno S, Oh S, Ueno T, Suzuki K, Yao T. PLoS One; 2013 Nov 10; 8(12):e81883. PubMed ID: 24339976 [Abstract] [Full Text] [Related]
11. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Cheng AL, Huang WG, Chen ZC, Peng F, Zhang PF, Li MY, Li F, Li JL, Li C, Yi H, Yi B, Xiao ZQ. Clin Cancer Res; 2008 Jan 15; 14(2):435-45. PubMed ID: 18223218 [Abstract] [Full Text] [Related]
12. Proteome of formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma and lymph node metastases. Naidoo K, Jones R, Dmitrovic B, Wijesuriya N, Kocher H, Hart IR, Crnogorac-Jurcevic T. J Pathol; 2012 Apr 15; 226(5):756-63. PubMed ID: 22081483 [Abstract] [Full Text] [Related]
13. Increased AAA-TOB3 correlates with lymph node metastasis and advanced stage of lung adenocarcinoma. Liu Y, Bu L, Li W, Wu W, Wang S, Diao X, Zhou J, Chen G, Yang S. Int J Biol Markers; 2017 Jul 24; 32(3):e325-e332. PubMed ID: 28623644 [Abstract] [Full Text] [Related]
14. Expression of Tiam1 predicts lymph node metastasis and poor survival of lung adenocarcinoma patients. Liu S, Li Y, Qi W, Zhao Y, Huang A, Sheng W, Lei B, Lin P, Zhu H, Li W, Shen H. Diagn Pathol; 2014 Mar 24; 9():69. PubMed ID: 24661909 [Abstract] [Full Text] [Related]
15. Identificating 14-3-3 sigma as a lymph node metastasis-related protein in human lung squamous carcinoma. Li DJ, Deng G, Xiao ZQ, Yao HX, Li C, Peng F, Li MY, Zhang PF, Chen YH, Chen ZC. Cancer Lett; 2009 Jun 28; 279(1):65-73. PubMed ID: 19231067 [Abstract] [Full Text] [Related]
16. Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis. Tian T, Hao J, Xu A, Hao J, Luo C, Liu C, Huang L, Xiao X, He D. Cancer Sci; 2007 Aug 28; 98(8):1265-74. PubMed ID: 17537172 [Abstract] [Full Text] [Related]
17. Proteomic analysis of laser-microdissected paraffin-embedded tissues: (1) Stage-related protein candidates upon non-metastatic lung adenocarcinoma. Kawamura T, Nomura M, Tojo H, Fujii K, Hamasaki H, Mikami S, Bando Y, Kato H, Nishimura T. J Proteomics; 2010 Apr 18; 73(6):1089-99. PubMed ID: 19948256 [Abstract] [Full Text] [Related]
18. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. Cheng AL, Huang WG, Chen ZC, Zhang PF, Li MY, Li F, Li JL, Li C, Yi H, Peng F, Duan CJ, Xiao ZQ. J Proteome Res; 2008 Jun 18; 7(6):2415-26. PubMed ID: 18433155 [Abstract] [Full Text] [Related]
19. Identification of biological properties of intralymphatic tumor related to the development of lymph node metastasis in lung adenocarcinoma. Kirita K, Ishii G, Matsuwaki R, Matsumura Y, Umemura S, Matsumoto S, Yoh K, Niho S, Goto K, Ohmatsu H, Ohe Y, Nagai K, Ochiai A. PLoS One; 2013 Jun 18; 8(12):e83537. PubMed ID: 24376714 [Abstract] [Full Text] [Related]
20. Id-1, Id-2, and Id-3 co-expression correlates with prognosis in stage I and II lung adenocarcinoma patients treated with surgery and adjuvant chemotherapy. Antonângelo L, Tuma T, Fabro A, Acencio M, Terra R, Parra E, Vargas F, Takagaki T, Capelozzi V. Exp Biol Med (Maywood); 2016 Jun 18; 241(11):1159-68. PubMed ID: 26869608 [Abstract] [Full Text] [Related] Page: [Next] [New Search]